Avrahami D - Search Results

1

Snord 3A: a molecular marker and modulator of prion disease progression.

Cohen E, Avrahami D, Frid K, Canello T, Levy Lahad E, Zeligson S, Perlberg S, Chapman J, Cohen OS, Kahana E, Lavon I, Gabizon R. Cohen E, et al. Among authors: avrahami d. PLoS One. 2013;8(1):e54433. doi: 10.1371/journal.pone.0054433. Epub 2013 Jan 21. PLoS One. 2013. PMID: 23349890 Free PMC article.

2

Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease.

Hsiao K, Meiner Z, Kahana E, Cass C, Kahana I, Avrahami D, Scarlato G, Abramsky O, Prusiner SB, Gabizon R. Hsiao K, et al. Among authors: avrahami d. N Engl J Med. 1991 Apr 18;324(16):1091-7. doi: 10.1056/NEJM199104183241604. N Engl J Med. 1991. PMID: 2008182 Free article.

3

Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time.

Mayer-Sonnenfeld T, Avrahami D, Friedman-Levi Y, Gabizon R. Mayer-Sonnenfeld T, et al. Among authors: avrahami d. Cell Mol Neurobiol. 2008 Nov;28(7):1005-15. doi: 10.1007/s10571-008-9274-1. Epub 2008 Mar 19. Cell Mol Neurobiol. 2008. PMID: 18350378

4

Virus-induced alterations of membrane lipids affect the incorporation of PrP Sc into cells.

Avrahami D, Dayan-Amouyal Y, Tal S, Mincberg M, Davis C, Abramsky O, Gabizon R. Avrahami D, et al. J Neurosci Res. 2008 Sep;86(12):2753-62. doi: 10.1002/jnr.21720. J Neurosci Res. 2008. PMID: 18478553

5

Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.

Haviv Y, Avrahami D, Ovadia H, Ben-Hur T, Gabizon R, Sharon R. Haviv Y, et al. Among authors: avrahami d. Arch Neurol. 2008 Jun;65(6):762-75. doi: 10.1001/archneur.65.6.762. Arch Neurol. 2008. PMID: 18541796

6

Age-related alterations affect the susceptibility of mice to prion infection.

Avrahami D, Gabizon R. Avrahami D, et al. Neurobiol Aging. 2011 Nov;32(11):2006-15. doi: 10.1016/j.neurobiolaging.2009.12.015. Epub 2009 Dec 31. Neurobiol Aging. 2011. PMID: 20045218

7

Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob disease.

Friedman-Levi Y, Meiner Z, Canello T, Frid K, Kovacs GG, Budka H, Avrahami D, Gabizon R. Friedman-Levi Y, et al. Among authors: avrahami d. PLoS Pathog. 2011 Nov;7(11):e1002350. doi: 10.1371/journal.ppat.1002350. Epub 2011 Nov 3. PLoS Pathog. 2011. PMID: 22072968 Free PMC article.

8

Correction: Fatal Prion Disease in a Mouse Model of Genetic E200K Creutzfeldt-Jakob Disease.

Friedman-Levi Y, Meiner Z, Canello T, Frid K, Kovacs GG, Budka H, Avrahami D, Gabizon R. Friedman-Levi Y, et al. Among authors: avrahami d. PLoS Pathog. 2017 May 3;13(5):e1006294. doi: 10.1371/journal.ppat.1006294. eCollection 2017 May. PLoS Pathog. 2017. PMID: 28467504 Free PMC article.

9

Inhibition of mTORC1 by ER stress impairs neonatal β-cell expansion and predisposes to diabetes in the Akita mouse.

Riahi Y, Israeli T, Yeroslaviz R, Chimenez S, Avrahami D, Stolovich-Rain M, Alter I, Sebag M, Polin N, Bernal-Mizrachi E, Dor Y, Cerasi E, Leibowitz G. Riahi Y, et al. Among authors: avrahami d. Elife. 2018 Nov 9;7:e38472. doi: 10.7554/eLife.38472. Elife. 2018. PMID: 30412050 Free PMC article.

10

Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform.

Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner SB. Taraboulos A, et al. Among authors: avrahami d. J Cell Biol. 1995 Apr;129(1):121-32. doi: 10.1083/jcb.129.1.121. J Cell Biol. 1995. PMID: 7698979 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters